JP2012510813A5 - - Google Patents

Download PDF

Info

Publication number
JP2012510813A5
JP2012510813A5 JP2011539528A JP2011539528A JP2012510813A5 JP 2012510813 A5 JP2012510813 A5 JP 2012510813A5 JP 2011539528 A JP2011539528 A JP 2011539528A JP 2011539528 A JP2011539528 A JP 2011539528A JP 2012510813 A5 JP2012510813 A5 JP 2012510813A5
Authority
JP
Japan
Prior art keywords
mir
biomarker
cell population
subject
test
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011539528A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012510813A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/038214 external-priority patent/WO2010065156A1/en
Publication of JP2012510813A publication Critical patent/JP2012510813A/ja
Publication of JP2012510813A5 publication Critical patent/JP2012510813A5/ja
Pending legal-status Critical Current

Links

JP2011539528A 2008-12-05 2009-03-25 卵巣癌の診断および治療のためのマイクロｒｎａに基づく方法および組成物 Pending JP2012510813A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12012308P 2008-12-05 2008-12-05
US61/120,123 2008-12-05
PCT/US2009/038214 WO2010065156A1 (en) 2008-12-05 2009-03-25 Microrna-based methods and compositions for the diagnosis and treatment of ovarian cancer

Publications (2)

Publication Number Publication Date
JP2012510813A JP2012510813A (ja) 2012-05-17
JP2012510813A5 true JP2012510813A5 (enExample) 2013-05-09

Family

ID=42233538

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011539528A Pending JP2012510813A (ja) 2008-12-05 2009-03-25 卵巣癌の診断および治療のためのマイクロｒｎａに基づく方法および組成物

Country Status (7)

Country Link
US (3) US20110275534A1 (enExample)
EP (1) EP2373815A4 (enExample)
JP (1) JP2012510813A (enExample)
CN (1) CN102292456A (enExample)
AU (2) AU2009322907B2 (enExample)
CA (1) CA2745746A1 (enExample)
WO (1) WO2010065156A1 (enExample)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102533966B (zh) 2005-08-01 2014-03-12 俄亥俄州立大学研究基金会 用于乳腺癌的诊断、预后和治疗的基于MicroRNA的方法和组合物
EP2796554A3 (en) 2005-09-12 2014-12-10 The Ohio State University Research Foundation Compositions for use in treating BCL2-associated cancers
CN101384273B (zh) 2006-01-05 2013-07-10 俄亥俄州立大学研究基金会 胰腺内分泌和腺泡肿瘤中的微小rna表达异常
CN103642900B (zh) 2006-01-05 2016-04-13 俄亥俄州立大学研究基金会 用于诊断和治疗实体癌的基于微小rna的方法和组合物
WO2007081720A2 (en) 2006-01-05 2007-07-19 The Ohio State University Research Foundation Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer
CN101448958A (zh) 2006-03-20 2009-06-03 俄亥俄州立大学研究基金会 人巨核细胞生成期间的微小rna指纹
EP2455492B1 (en) 2006-07-13 2013-11-20 The Ohio State University Research Foundation Micro-RNA-based methods and compositions for the diagnosis and treatment of colon related diseases
EP2061907B1 (en) 2006-09-19 2011-11-23 The Ohio State University Research Foundation Tcl1 expression in chronic lymphocytic leukemia (cll) regulated by mir-29 and mir-181
EP2087135B8 (en) 2006-11-01 2013-07-24 The Ohio State University Research Foundation Microrna expression signature for predicting survival and metastases in hepatocellular carcinoma
WO2008094545A2 (en) 2007-01-31 2008-08-07 The Ohio State University Research Foundation Mic orna-based methods and compositions for the treatment of acute myeloid leukemia
WO2008153987A2 (en) 2007-06-08 2008-12-18 The Government Of The United States Of America As Represented By The Secretary Of Department Of Health And Human Services Methods for determining hepatocellular carcinoma subtype and detecting hepatic cancer stem cells
AU2008266014B2 (en) 2007-06-15 2013-06-06 The Ohio State University Research Foundation Oncogenic ALL-1 fusion proteins for targeting drosha-mediated microRNA processing
WO2009018303A2 (en) 2007-07-31 2009-02-05 The Ohio State University Research Foundation Methods for reverting methylation by targeting dnmt3a and dnmt3b
ES2627059T3 (es) 2007-08-03 2017-07-26 The Ohio State University Research Foundation Regiones ultraconservadas que codifican ARNnc
ES2562078T3 (es) 2007-08-22 2016-03-02 The Ohio State University Research Foundation Métodos y composiciones para inducir la desregulación de la fosforilación de EphA7 y ERK en leucemias agudas humanas
WO2009055773A2 (en) 2007-10-26 2009-04-30 The Ohio State University Research Foundation Methods for identifying fragile histidine triad (fhit) interaction and uses thereof
WO2009108853A1 (en) * 2008-02-28 2009-09-03 The Ohio State University Research Foundation MicroRNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF GASTRIC CANCER
WO2009152300A1 (en) 2008-06-11 2009-12-17 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Use of mir-26 family as a predictive marker of hepatocellular carcinoma and responsiveness to therapy
CA2781547A1 (en) 2009-11-23 2011-05-26 The Ohio State University Materials and methods useful for affecting tumor cell growth, migration and invasion
JP6081798B2 (ja) * 2010-02-26 2017-02-15 メモリアル スローン−ケタリング キャンサー センター ｍｉＲＮＡに関連する癌を検出および処置するための方法および組成物およびｍｉＲＮＡインヒビターおよび標的
WO2012065049A1 (en) 2010-11-12 2012-05-18 The Ohio State University Research Foundation Materials and methods related to microrna-21, mismatch repair, and colorectal cancer
AU2011329066B2 (en) 2010-11-15 2017-03-09 The Ohio State University Research Foundation Controlled release mucoadhesive systems
WO2012122239A1 (en) 2011-03-07 2012-09-13 The Ohio State University MUTATOR ACTIVITY INDUCED BY MICRORNA-155 (miR-155) LINKS INFLAMMATION AND CANCER
US20120251619A1 (en) * 2011-03-31 2012-10-04 Gunaratne Preethi H MicroRNA-29a,b,c as a Tumor Suppressor and Sensitizing Agent for Chemotherapy
AU2012323924A1 (en) * 2011-10-14 2014-05-29 The Ohio State University Methods and materials related to ovarian cancer
AU2012352265B2 (en) * 2011-12-13 2017-02-16 Ohio State Innovation Foundation Methods and compositions related to miR-21 and miR-29a, exosome inhibition, and cancer metastasis
EP2804960A4 (en) 2012-01-20 2015-08-19 Univ Ohio State BREAST CANCER BIOMARK SIGNATURES FOR INVASIVITY AND FORECAST
WO2014071226A1 (en) 2012-11-02 2014-05-08 The Regents Of The University Of California Methods and systems for determining a likelihood of adverse prostate cancer pathology
CN104123480B (zh) * 2013-04-27 2017-03-08 中国科学院上海生命科学研究院 新型微rna筛选方法、验证系统及其应用
KR101508580B1 (ko) 2013-05-14 2015-04-07 연세대학교 산학협력단 재발성 난소암의 예측 또는 진단 방법
CN103952465A (zh) * 2013-12-10 2014-07-30 长沙赢润生物技术有限公司 一种基于血浆microRNA分析的卵巢癌肿瘤诊断方法
KR101784714B1 (ko) 2014-08-19 2017-10-12 주식회사 엠모니터 재발 난소암 진단 또는 난소암 재발 예측용 mirna 마커 및 그 용도
WO2017040311A1 (en) * 2015-08-28 2017-03-09 The Trustees Of Columbia University In The City Of New York Systems and methods for matching oncology signatures
EP3147370A1 (en) * 2015-09-28 2017-03-29 Rheinische Friedrich-Wilhelms-Universität Bonn Exosomal microrna in serum as an indicator for the activation of brown and beige fat tissue (bat)
CN105177173A (zh) * 2015-11-02 2015-12-23 崔长友 用于卵巢癌诊断的miRNA生物标志物及检测试剂盒
CN109564151B (zh) 2016-03-17 2023-01-24 贝克顿·迪金森公司 使用高通量荧光流式细胞仪进行细胞分选
CN105695612A (zh) * 2016-04-19 2016-06-22 中南大学 microRNA-126-5p在心肌损伤中的表达检测方法
CN106520924A (zh) * 2016-10-14 2017-03-22 浙江大学 一种用于检测卵巢癌的引物组及检测方法
US11236337B2 (en) 2016-11-01 2022-02-01 The Research Foundation For The State University Of New York 5-halouracil-modified microRNAs and their use in the treatment of cancer
US11584932B2 (en) 2016-11-01 2023-02-21 The Research Foundation For The State University Of New York 5-halouracil-modified microRNAs and their use in the treatment of cancer
EP3565903A4 (en) * 2017-01-09 2020-12-23 Dana-Farber Cancer Institute, Inc. CIRCULATING MICRORNA SIGNATURES FOR OVARIAN CANCER
CN111278844B (zh) 2017-09-13 2023-12-19 贝克顿·迪金森公司 用于使用氧化铁颗粒提取核酸的方法和组合物
ES3044114T3 (en) * 2018-07-05 2025-11-26 Univ Caen Predictive and prognostic use of a mirna for high grade serous ovarian carcinoma therapeutic care
KR20210137828A (ko) * 2020-05-11 2021-11-18 의료법인 성광의료재단 기계학습 예측모델을 이용한 난소암 진단 방법 및 이를 적용하는 시스템
WO2021262919A2 (en) 2020-06-26 2021-12-30 The Research Foundation For The State University Of New York 5-halouracil-modified micrornas and their use in the treatment of cancer
CN112626209A (zh) * 2020-12-22 2021-04-09 绵竹市人民医院 用于卵巢癌诊断的miRNA标志物、其应用及诊断试剂盒

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050182005A1 (en) * 2004-02-13 2005-08-18 Tuschl Thomas H. Anti-microRNA oligonucleotide molecules
CN102533966B (zh) * 2005-08-01 2014-03-12 俄亥俄州立大学研究基金会 用于乳腺癌的诊断、预后和治疗的基于MicroRNA的方法和组合物
CN103642900B (zh) * 2006-01-05 2016-04-13 俄亥俄州立大学研究基金会 用于诊断和治疗实体癌的基于微小rna的方法和组合物
JP2010500867A (ja) * 2006-06-30 2010-01-14 ロゼッタ ジノミクス リミテッド 核酸の検出方法

Similar Documents

Publication Publication Date Title
JP2012510813A5 (enExample)
Hui et al. Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues
Islam et al. RNA biomarkers: diagnostic and prognostic potentials and recent developments of electrochemical biosensors
Song et al. Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer
CN103717755B (zh) 预测dlbcl患者对于抗-cd20治疗的响应
Gu et al. Detection of miRNAs with a nanopore single-molecule counter
AU2021212151B2 (en) Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm
KR101987358B1 (ko) 신규한 간암 진단용 바이오 마커 및 이의 용도
JP6581502B2 (ja) 初期段階の肺がんにおける予後指標としてのタンパク質コーディング遺伝子及び非コーディング遺伝子の発現
CN100393886C (zh) 结直肠癌的预后
WO2016097120A1 (en) Method for the prognosis of hepatocellular carcinoma
US20160281176A1 (en) Method for predicting the outcome of colon cancer by analysing mirna expression
Marín-Romero et al. A PCR-free technology to detect and quantify microRNAs directly from human plasma
Al Sulaiman et al. High-resolution patterning of hydrogel sensing motifs within fibrous substrates for sensitive and multiplexed detection of biomarkers
CN110747269A (zh) 用于pcos诊断的颗粒细胞生物标志物及其筛选方法和诊断试剂盒
Tölle et al. miRNA panels as biomarkers for bladder cancer
Shaker et al. Circulating miRNA and circulating tumor DNA application as liquid biopsy markers in gastric cancer
US20210381057A1 (en) Recurrence gene signature across multiple cancer types
CN107299129B (zh) 循环核酸作为乳腺癌生物标志物的应用
US20180274037A1 (en) Novel biomarkers for pancreatic diseases
US20150329911A1 (en) Nucleic acid biomarkers for prostate cancer
CN113481282B (zh) 一种用于分析circRNA-microRNA相互作用的二合一集成测定法
KR101967100B1 (ko) 대장암의 림프절 전이를 진단하기 위한 miRNA 분별자 및 이를 이용한 대장암에서 림프절 전이 진단 방법
CN112195240A (zh) Mthfd2蛋白作为食管癌转移诊断和/或预后评估的生物标记及其应用
WO2016199094A1 (en) Mirna aberration(s) in squamous cell carcinoma of head and neck (hnscc) and applications thereof